Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway - Wikidata - wikimedia - TriplyDB

Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway

Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway

http://www.wikidata.org/entity/Q28274746

about

VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta Protein kinase D in vascular biology and angiogenesis Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancer Increased Skin Tumor Incidence and Keratinocyte Hyper-Proliferation in a Mouse Model of Down Syndrome Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.NFAT proteins: emerging roles in cancer progression.Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.Overexpression of Rcan1-1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer.Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension Requirement of novel amino acid fragments of orphan nuclear receptor TR3/Nur77 for its functions in angiogenesis Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7.Nuclear localization of TEF3-1 promotes cell cycle progression and angiogenesis in cancer.KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice Role of Phosphorylated HDAC4 in Stroke-Induced Angiogenesis.Calcineurin-NFAT activation and DSCR-1 auto-inhibitory loop: how is homoeostasis regulated?Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor gamma and calcium signaling in human colorectal cancer cells.mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.RCAN1-4 knockdown attenuates cell growth through the inhibition of Ras signaling.Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.Spatial control of calcineurin in response to heat shock in fission yeast.Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.VEGF inhibitor (Iressa) arrests histone deacetylase expression: single-cell cotransfection imaging cytometry for multi-target-multi-drug analysis.

P2860

Q21136325-F78AAA8F-F19A-4366-B32F-E2FC673B7D11 Q24299665-15D40EF5-1529-4DE4-8A8A-25E736E152C0 Q26824937-FF169A56-F050-4499-BE8F-5225CECFCB80 Q28552259-4E9FBD89-4DD6-4E67-AA54-26ACE57E196A Q33293466-95F17A8E-D195-4EA3-AFBC-7D5958DB7D6D Q33556402-52DF9318-3BCB-43A4-95C4-2A2A2027B512 Q33837647-B0F23C64-FB4A-4F1D-AC49-233A0700FD63 Q33969060-A9E4A49F-B817-480A-A5FA-D9B62D022649 Q34268889-5690B8B3-6517-4127-BE3C-501B34FC7B93 Q34628223-6CE13539-EBBA-4527-92E5-D36F7D4009E9 Q35630191-80F869F4-52BC-4167-A75D-6960489BB7FD Q36093897-E3127617-CCC5-46DE-9765-A1591758950D Q36414440-EFDB2280-E5A5-4C85-98C3-C933E78793E4 Q36581939-9D6A860F-1414-4CAC-A162-7807E6B85161 Q36693824-BB709ACC-25BE-4303-AA80-10411BD68206 Q37046471-95ABB8B7-E3FB-4DFD-AE9A-98486C8D8FB0 Q37224269-0AFF5D0D-FF0B-4D4B-97CE-1985885D0546 Q37254801-AFB8EFC2-A8B2-40EB-B2E3-9852F17490C0 Q37286605-33DC7C64-35D5-4838-BACD-449CBD080D5E Q37588724-354ED846-9D1D-4A59-989B-B0CED800CFE0 Q38186014-4026ED60-FD78-45F5-A187-E13F9CF8979C Q38206125-DB903415-E426-4264-B61F-BF706E7C37B3 Q38516045-C62D3157-E110-4304-B075-5DC4F1A32684 Q38703520-16BCE2BF-3F71-435B-A792-C677576169C8 Q39823032-DCBFAA43-E9F6-4586-B2D9-BF80B369261F Q39987047-01E607EC-96F1-4600-B19A-A130EB85A457 Q41775575-155FDA37-C8EC-4701-BC2A-D4FEEF6E4CD3 Q41898539-0CBA8854-F66A-494B-8797-BA95B6AEEF53 Q52981019-D5FC8C17-28CD-4537-B227-DE18571A0BE1 Q53195733-EF61FABF-88D8-4B0E-B0F4-2D40024F6139 Q54594309-D2E4737D-F0E6-458C-B730-9218A9B412A2

P2860

Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway

http://www.wikidata.org/entity/Q28274746

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@ast

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@en

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@nl

type

label

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@ast

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@en

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@nl

prefLabel

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@ast

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@en

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@nl

P1433

Q28274746-E0D6D585-4DB2-40A0-A1C2-C702FAA61328

P1476

Q28274746-5B4434B1-BEED-4754-A567-FA10167B607D

P2093

Q28274746-0264E7B3-EA5D-4114-B3DB-449DC29511CB

Q28274746-08258468-D83C-40E9-93A9-219091772C9A

Q28274746-10A17D15-D826-476B-A585-19CFEA211B88

Q28274746-2E6C374A-0D57-4DB3-A032-3FA1B239E521

Q28274746-41367A01-98F9-4F78-BF1D-1B56875F28EE

Q28274746-69403836-50A3-4C68-9383-8A50E6D0CF8F

Q28274746-96AE2D56-C175-495F-9117-205B735AF6D8

Q28274746-EBD08068-DC05-48D6-8C50-FA2599E0EAEC

P304

Q28274746-CFAF5EA9-2042-456E-BB11-264F8982AB85

P31

Q28274746-1CA2E29D-02BF-4433-A83D-B7B52EB067EA

P3181

Q28274746-1C4605DD-5B5C-4C73-877A-1A23792AD6B5

P356

Q28274746-B0C44D39-B192-44F9-9AD2-7E60F999B99D

P407

Q28274746-81E9ABE3-B7B7-4235-B0D2-B28A2E839D09

P433

Q28274746-CC760BF9-259E-478D-AFF2-E63726C001CB

P478

Q28274746-B82310A4-2335-49B9-BB59-77B92A2911A1

P577

Q28274746-5F8E0790-84E3-45D0-81A7-0C85879DD27E

P698

Q28274746-2110CDDC-A29E-4926-944B-09E2DE191623

P3181

P356

1541-7786.MCR-06-0126

P1433

Molecular Cancer Research

P1476

Down syndrome candidate region ...... h the calcineurin-NFAT pathway

@en

P2093

Dezheng Zhao

http://www.w3.org/2001/XMLSchema#string

Harold F Dvorak

http://www.w3.org/2001/XMLSchema#string

Huiyan Zeng

http://www.w3.org/2001/XMLSchema#string

Janice A Nagy

http://www.w3.org/2001/XMLSchema#string

Lawrence F Brown

http://www.w3.org/2001/XMLSchema#string

Liuliang Qin

http://www.w3.org/2001/XMLSchema#string

Mien Van Hoang

http://www.w3.org/2001/XMLSchema#string

Xin Liu

http://www.w3.org/2001/XMLSchema#string

P304

811-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4084142

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1541-7786.MCR-06-0126

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17114339

http://www.w3.org/2001/XMLSchema#string